A Phase II, Open-label, Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Rate of local response and depth of tumoricidal tissue penetration of Foscan-PDT
post treatment
No
Frieder Berr, Prof., MD
Principal Investigator
Department of Internal Medicine I, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria
Austria : Federal Ministry for Labour, Health, and Social Affairs
Foscan 1/2005
NCT01016002
January 2006
Name | Location |
---|